Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.

W Reinisch; S Angelberger; Wolfgang Petritsch; O Shonova; M Lukas; S Bar-Meir; A Teml; E Schaeffeler; M Schwab; K Dilger; R Greinwald; R Mueller; EF Stange; KR Herrlinger; International AZT-2 Study Group; Jörg Jahnel

doi:10.1136/gut.2009.194159

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.

W Reinisch
, S Angelberger
, Wolfgang Petritsch
, O Shonova
, M Lukas
, S Bar-Meir
, A Teml
, E Schaeffeler
, M Schwab
, K Dilger
, R Greinwald
, R Mueller
, EF Stange
, KR Herrlinger
, International AZT-2 Study Group
, Jörg Jahnel (Collaborator)

Division of Gastroenterology and Hepatology

Research output: Contribution to journal › Research article

144 Citations (Web of Science)

Original language	English
Journal	Gut
DOIs	https://doi.org/10.1136/gut.2009.194159
Publication status	Published - 2010

Branches of science

302 Clinical Medicine

DOI

10.1136/gut.2009.194159

Links

Cite this

Reinisch, W., Angelberger, S., Petritsch, W., Shonova, O., Lukas, M., Bar-Meir, S., Teml, A., Schaeffeler, E., Schwab, M., Dilger, K., Greinwald, R., Mueller, R., Stange, EF., Herrlinger, KR., International AZT-2 Study Group, & Jahnel, J. (2010). Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial. Gut. https://doi.org/10.1136/gut.2009.194159

@article{2a9eaf57388d49428a30cf41a256feba,

title = "Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.",

author = "W Reinisch and S Angelberger and Wolfgang Petritsch and O Shonova and M Lukas and S Bar-Meir and A Teml and E Schaeffeler and M Schwab and K Dilger and R Greinwald and R Mueller and EF Stange and KR Herrlinger and \{International AZT-2 Study Group\} and J{\"o}rg Jahnel",

year = "2010",

doi = "10.1136/gut.2009.194159",

language = "English",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

}

Reinisch, W, Angelberger, S, Petritsch, W, Shonova, O, Lukas, M, Bar-Meir, S, Teml, A, Schaeffeler, E, Schwab, M, Dilger, K, Greinwald, R, Mueller, R, Stange, EF, Herrlinger, KR, International AZT-2 Study Group & Jahnel, J 2010, 'Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.', Gut. https://doi.org/10.1136/gut.2009.194159

TY - JOUR

T1 - Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.

AU - Reinisch, W

AU - Angelberger, S

AU - Petritsch, Wolfgang

AU - Shonova, O

AU - Lukas, M

AU - Bar-Meir, S

AU - Teml, A

AU - Schaeffeler, E

AU - Schwab, M

AU - Dilger, K

AU - Greinwald, R

AU - Mueller, R

AU - Stange, EF

AU - Herrlinger, KR

AU - International AZT-2 Study Group

A2 - Jahnel, Jörg

PY - 2010

Y1 - 2010

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000278387700012

UR - https://pubmed.ncbi.nlm.nih.gov/20551460

U2 - 10.1136/gut.2009.194159

DO - 10.1136/gut.2009.194159

M3 - Research article

C2 - 20551460

SN - 0017-5749

JO - Gut

JF - Gut

ER -